The EUR88 billion biotechnology market was still relatively immature; none of the pure biotech firms were featured as leading players within the overall P&B industry. Instead, the top six players overall were all pharmaceutical giants. Collectively, these top six controlled 29% of the global market. Pfizer was the clear leader with Sanofi-Aventis and GlaxoSmithKline closely matched for the number two position